Beruflich Dokumente
Kultur Dokumente
Cluster headache
Revised: October 14, 2013
Copyright Elsevier BV. All rights reserved.
Key points
Cluster headaches are recurrent episodes of excruciatingly severe, unilateral
headache/facial pain
Patients usually present with intense, penetrating or boring pain that is typically
localized in the periorbital area and temple. Cluster headaches are often associated
with ipsilateral autonomic nervous system dysfunction such as tearing, sweating, and
miosis
Diagnosis is largely based on history and clinical features; diagnostic tests are
performed to rule out alternate diagnoses
Patients should avoid known triggers such as alcohol, bright lights and glare, sleep
deprivation, and stress
Acute treatments such as triptans and ergotamines are available to shorten the
cluster period or prevent anticipated attacks but may not be effective in all patients.
In the clinic or hospital setting, 100% oxygen via face mask may abort the attack
Prophylactic treatments are also available; these are important because of the limited
usefulness of abortive agents and the intense nature of the pain
Background
Description
Recurrent episodes of excruciatingly severe unilateral headache/facial pain
Can last 15 to 180 minutes, although most attacks are less than 1 hour's duration;
can occur up to eight times per day
During a cluster period, attacks often assume temporal cyclicity with attacks at
almost the same time each day. Headache typically begins a few hours after the
patient goes to bed or while relaxing after work in the late afternoon
Associated with one or more autonomic nervous system dysfunctions on the side
experiencing pain: tearing, red eye, puffy eyelid, stuffy/runny nose, facial
sweating, ptosis, miosis
Chronic
Approximately 20% of patients
Epidemiology
Incidence and prevalence
Demographics
Age:
Gender:
Genetics:
Etiology unknown for the cause of cluster headache or its associated autonomic
dysfunction
Alcohol
Vasodilators ( eg , nitroglycerin)
Male gender
Family history of cluster headaches. Genetic factors may contribute, but to date no
specific gene has been identified
Screening
Summary approach
Not applicable.
Primary prevention
Summary approach
Not applicable.
Diagnosis
Summary approach
Sudden onset of severe headache, reaching a crescendo within 15 minutes and
lasting 30 to 180 minutes (although most attacks are less than 1 hour's duration);
can occur one to eight times per day
Attacks may occur at the same time on consecutive days; frequently an attack
occurs within 90 minutes of falling asleep, corresponding to first rapid eye
movement (REM) sleep
Patients usually present with intense, penetrating or boring pain that is typically
localized in the periorbital area and temple
Clinical presentation
Symptoms
Perspiration
Facial flushing
History of alcohol use; small amounts of alcohol may trigger cluster headache
Patients who do not see a dentist for regular checkups are more likely to have
active dental disease, which might be the cause of acute facial pain rather than
cluster headaches
Signs
Bradycardia
Conjunctival injection
Facial sweating
Eyelid edema
Between headaches the examination is normal, although residual Horner syndrome can
be seen when the patient is examined during the headache:
If the patient looks unwell, check for localized infection and neck stiffness; exclude
serious conditions such as meningitis and subarachnoid hemorrhage
Check the patient's blood pressure and temperature. Raised blood pressure may
suggest hypertensive headache or pheochromocytoma . Raised intracranial pressure may
also present with raised blood pressure and a slow pulse
Check pupils for loss of reactivity, which suggests Horner syndrome, and corneas
for clouding, which is indicative of acute glaucoma
Check for purulent nasal discharge. Feel the temporomandibular joint as the
patient opens and closes jaw. Crepitus is a suspicious feature; some clicking is not
unusual, but if marked it may be suggestive of dysfunction
Conduct a careful and complete neurologic examination to rule out a fixed focal deficit,
which may indicate intracranial pathology:
Test cranial nerves and check that power, tone, sensation, coordination, and
reflexes are normal in all four limbs
Look for ataxia, alteration of mental status, focal deficits, and meningeal signs
Diagnostic testing
Diagnostic tests are performed to rule out alternative diagnoses:
Computed tomography (CT) scan (178027210_618)is the test of choice for emergent
detection of potentially life-threatening lesions
Description
Normal results
Comments
ESR increases with age; rarely, values above 50 mm/h may be normal in patients
aged over 70 years
Marker of inflammation in the serum; measures the acute phase response to
inflammation
If results are negative, checking C-reactive protein can increase sensitivity when
temporal arteritis is suspected
Description
Normal results
Neutrophils—bands: 0 to 700/µL
Monocytes: 0 to 800/µL
Eosinophils: 0 to 450/µL
Basophils: 0 to 200/µL
Comments
Normal in cluster headache
Levels may be depressed in anemia due to iron deficiency, chronic blood loss,
chronic hemolysis, or marrow failure
Description
Normal results
Comments
Biopsy can confirm the diagnosis of giant cell arteritis; however, it is invasive
and cannot definitively rule out temporal arteritis since the area of biopsy may
miss the zone of inflammation
Description
Normal results
Comments
Lumbar puncture
Description
A needle is placed in the lumbar cistern to measure CSF pressure and to collect
CSF for analysis
Normal results
Comments
Lumbar puncture identifies many cases of viral and bacterial meningitis and is
very sensitive for the detection of small amounts of subarachnoid blood
(xanthochromia)
Has a small potential for serious adverse effects, including herniation, if there is
a structural cause for increased intracranial pressure. Imaging should be
performed before the lumbar puncture in most circumstances
Abnormal results:
Increased CSF pressure is seen in patients with pseudotumor cerebri, some
infections, and venous thrombosis
Description
Normal results
Comments
MRI provides a sensitive evaluation for many serious causes of headache, such
as infiltrating brain masses
Does not usually show meningitis and some causes of encephalitis that may
present with headaches
Differential diagnosis
Migraine
Dental disease
Chronic dull, aching, unilateral discomfort over the jaw, behind the eyes and
ears, and possibly down the neck and into the shoulders
Jaw with clicking sounds and difficulty opening mouth in the morning
Painful lesions of the middle ear, including otitis media , cholesteatoma , and
mastoiditis , may cause headache
Most commonly, ear pain refers to the throat and in front of the auricle
Scalp tenderness, especially when the hair is combed, localized to the involved
vessel(s)
Substance-induced headache
Occurs with acute exposure to substances such as alcohol , carbon monoxide , and
indomethacin
Trigeminal neuralgia
Trigeminal neuralgia ('tic douloureux') is one of the most severe pain syndromes.
This is a prototypical neuropathic pain syndrome
Trigger zone is located within the region of pain, and pain may be provoked by
stimulation of areas on the face quite discrete from the site of pain
Sinusitis
'Heavy-headed' feeling
Reduced vision
Red eye
Subarachnoid hemorrhage
Usually dull and bifrontal pain, although pain tends to be worse on the side with
the tumor
Nocturnal awakening
Pheochromocytoma
Often similar to cluster headache in that they recur daily, last less than 1 hour,
and have associated autonomic symptoms such as tachycardia, sweating, and
blood pressure changes. However, autonomic symptoms such as sweating
should be diffuse, not just on the side with the headache
Consultation
Dentistry consultation may be needed to ascertain that pain does not originate
from an impacted wisdom tooth
Consultation with an ear, nose, and throat specialist may be required for diagnosis
and treatment of sinusitis
Treatment
Summary approach
Acute treatments are available to shorten the cluster period or prevent anticipated
attacks
Prophylactic treatments are also available; these are important because of the
limited usefulness of abortive agents and the intense nature of the pain
Avoid analgesic therapy for acute attacks, especially narcotic analgesics. Some
experts believe that narcotic analgesia changes the nature of the headache from
episodic to chronic cluster headache
Dihydroergotamine : rapid onset of action, but frequency of headaches limits use for
cluster
Ergotamine : relatively slow onset of action when given orally often limits usefulness
Lidocaine : can be administered intranasally on the same side as the symptoms and
is occasionally helpful. Should only be performed by those trained in its
administration
Prophylactic treatments:
Amitriptyline , selective serotonin reuptake inhibitors (SSRIs) (178214281_686), and clonidine have
all been used with some success in the prevention of cluster headaches; however,
their role in therapy is yet to be defined
Civamide (1425059): One small study demonstrated limited efficacy for preventing the
development of cluster headaches. A pharmaceutical company-sponsored trial
(http://clinicaltrials.gov/ct2/show/NCT01341548)is currently underway
Medications
Oxygen
Indication
Dose information
Adults:
Major contraindications
Comments
Evidence
A double-blind crossover study compared oxygen versus air inhalation at 6
L/min via nonrebreathing face masks for 15 minutes or less, for up to six
headaches. Oxygen-treated patients showed a significantly higher pain-relief
score. [1] Level of evidence: 2
References
Triptans
Indication
Dose information
Adults
Eletriptan :
Maximum: 80 mg/d
Naratriptan :
Maximum: 5 mg/d
Rizatriptan :
Maximum: 20 mg/d
Sumatriptan :
Zolmitriptan :
Maximum: 10 mg/d
Major contraindications
Angina
Arteriosclerosis
Basilar/hemiplegic migraine
Cardiac disease
Hypertension
Vasospastic angina
Comments
Triptans can have a dramatic effect in curtailing a cluster headache and are the
mainstay in acute treatment if oxygen fails to produce an adequate response
Serious adverse effects, including myocardial infarction, stroke, and death, limit
their use
Clinical trials of triptans did not include patients over 65 years of age, so clinical
information is not available for patients above this age group. In general, the
use of triptans in elderly patients is not recommended since these patients have
a higher incidence of declined hepatic activity, which may lead to a higher risk
of coronary artery disease and sudden surges in blood pressure
Evidence
A randomized, double-blind, placebo-controlled crossover trial of
subcutaneous sumatriptan found a significant increase in pain-free rates 10
to 15 minutes after administration of sumatriptan compared with placebo. [4]
Level of evidence: 2
A systematic review of six trials with a total of 999 study subjects determined
the efficacy and tolerability of a single dose of triptan for the treatment of
acute attacks of cluster headache. In total, 231 patients were treated with
zolmitriptan 5 mg, 223 patients with zolmitriptan 10 mg, 131 patients with
sumatriptan 6 mg, 88 patients with sumatriptan 12 mg, and 326 patients were
on placebo. Zolmitriptan was given orally or intranasally, and sumatriptan
was administered either subcutaneously or intranasally. In general, the
triptans used in these trials demonstrated superiority over placebo for
headache relief and pain-free responses, with a number needed to treat
(NNT) of 2.4 for 15-minute pain relief with subcutaneous sumatriptan 6 mg
(75% with sumatriptan and 32% with placebo), and an NNT of 2.8 for 30-
minute pain relief with intranasal zolmitriptan 10 mg (62% with zolmitriptan
and 26% with placebo). Smaller numbers of patients who were treated with
triptans required rescue therapy compared to the placebo group; however,
adverse events were more frequent in the treatment group. The authors
concluded that both zolmitriptan and sumatriptan were effective in the
treatment of acute bouts of cluster headache, were more convenient than
oxygen treatment, and demonstrated better safety and tolerability profiles
than ergotamine. Administration of the medication via non-oral routes was
associated with faster therapeutic response and relief. [6] Level of evidence: 1
References
Prednisone
Indication
Dose information
Adults
Acute treatment:
Prophylactic treatment:
Major contraindications
Fungal infection
Comments
Evidence
In a study of 19 patients with cluster headaches whose pain was not mitigated
by standard treatment, a double-blind control study with single crossover
showed sustained improvement on oral prednisone compared with placebo
in 17 cases. [7] Level of evidence: 3
References
Ergotamines
Indication
Abortive treatment
Dose information
Adults
Dihydroergotamine :
Ergotamine :
2 mg orally at onset, may be repeated at 1-hour interval, then not repeated for 4
days
Maximum: 6 mg/d or 10 mg/wk
Major contraindications
Angina (dihydroergotamine)
Breastfeeding (dihydroergotamine)
Eclampsia
Hypertension
Labor
Malnutrition (ergotamine)
Obstetric delivery
Preeclampsia
Pregnancy
Sepsis
Surgery (dihydroergotamine)
Comments
Evidence
A small double-blind, placebo-controlled trial showed a significant effect on
the intensity of single pain attacks with dihydroergotamine nasal spray. [8]
Level of evidence: 2
References
Lidocaine
Indication
Dose information
Maximum: 8 mL/d
Major contraindications
Sepsis
Comments
Viscous solution is for topical use only and must not be used for injection
Evidence
Nitroglycerin-induced pain in cluster headache showed a prompt response
with cessation of pain after local application of cocaine hydrochloride or
lidocaine in the area corresponding to the sphenopalatine fossa, under
anterior rhinoscopy. [9] Level of evidence: 2
References
Verapamil
Indication
Dose information
Adults:
Major contraindications
Atrioventricular block
Cardiogenic shock
Heart failure
Hypotension
Lown-Ganong-Levine syndrome
Ventricular dysfunction
Ventricular tachycardia
Wolff-Parkinson-White syndrome
Comments
Can cause a fall in blood pressure and should be used with caution in patients
with existing cardiac complications
Patients who are treated with doses more than 120 mg need electrocardiogram
monitoring because of the risk of dysrhythmias
Evidence
A small RCT compared the efficacy of verapamil versus placebo in the
prophylaxis of episodic cluster headache. There was a significant reduction in
the frequency of attacks and in the consumption of abortive agents in the
verapamil-treated group, suggesting that verapamil is effective in episodic
cluster headache prophylaxis. [10] Level of evidence: 2
References
Lithium
Indication
Dose information
Adults:
Comments
The narrow therapeutic index increases the risk of toxicity associated with the
use of lithium, especially at the higher doses given for cluster headache
prophylaxis
The adverse effect profile and toxicity problems limit its use and patient
acceptability
Evidence
In a double-dummy, double-blind, crossover comparison of verapamil with
lithium carbonate in preventing chronic cluster headache attacks, both
agents were found to be effective in preventing chronic cluster headache
attacks, but verapamil caused fewer adverse effects and had a shorter latency
period. [11] Level of evidence: 2
References
Topiramate
Indication
Dose information
Adults:
Comments
Gabapentin
Indication
Dose information
Adults:
Initially 300 mg orally twice a day, increased up to 2,400 mg/d in equally divided
doses
Comments
There is evidence to support its use in neuropathic pain; however, this has not
been extended to cluster headaches
Valproic acid
Indication
Dose information
Adults, extended-release:
Major contraindications
Hepatic disease
Mitochondrial disease
Comments
Beta-blockers
Indication
Dose information
Adults
Atenolol :
Nadolol :
Propranolol :
Major contraindications
Atrioventricular block
Bradycardia
Cardiogenic shock
Comments
Indication
Dose information
Adults:
10 to 25 mg orally at night
Major contraindications
Carbamazepine hypersensitivity
MAOI therapy
Comments
Indication
Dose information
Adults
Citalopram :
Maximum: 60 mg/d
Fluoxetine :
Paroxetine :
Maximum: 50 mg/d
Major contraindications
Pregnancy (paroxetine)
Comments
Clonidine
Indication
Dose information
Adults:
Comments
Civamide
Indication
25 μg/d
Major contraindications
Comments
Limited evidence indicates that intranasal civamide 100 μg of 0.025% (25 μg) is
effective in improving headache responses in patients with cluster headache
Evidence
A multi-center, double-blind, randomized study assessed the safety and
efficacy of intranasal civamide solution for prevention treatment in patients
with an episodic cluster headache period. A group of 28 patients with cluster
headache were treated with either 100 μL (25 μg) of 0.025% civamide or its
vehicle into each nostril daily for 1 week. The study subjects were followed-
up for 20 days after the initial treatment. Patients who received civamide
showed a greater decline in the number of headaches compared to the
placebo-treated group during days 1 through 7 (−55.5% vs −25.9%; P = .03).
There was only a trend toward significant improvement during days 8
through 14 (−66.9% vs −32.3%; P = .07) and days 15 through 20 (−70.6% vs
−34.9%; P = .07) compared to the vehicle group. The number of headaches per
week during the posttreatment period in the civamide-treated group
decreased more, with trends toward significance during posttreatment days 8
through 14 (−8.6 vs −3.6; P = .09) and days 15 through 20 (−8.9 vs −3.6; P = .07).
The most frequent adverse effects included nasal burning, lacrimation,
pharyngitis, and rhinorrhea. [12] Level of evidence: 3
References
Non-drug treatments
Trigeminal ganglion procedures
Description
Reserved for patients whose headaches are completely refractory to all medical
therapies
Complications
Temporary blindness secondary to the spread of the local anesthetic to the optic
nerve
Comments
Glycerol injection into trigeminal cistern gives significant pain relief in patients
with intractable cluster headache
Description
Indications
These treatments may help people manage severe pain and cope better with
disabilities associated with chronic or recurrent pain
Complications
Comments
Cognitive behavior therapy is the treatment that helps people test and revise
their thoughts and actions
Persons properly trained and certified in the techniques being offered should be
sought for these therapies
Special circumstances
Comorbidities
Special populations:
Consultation
Patients with intractable bouts of cluster headache who have failed medical treatment
should be referred to a neurosurgeon for surgical treatment of pain.
Follow-up
Monitoring:
Prognosis:
Most patients with cluster headache respond to abortive and preventive medication
Complications:
During cluster periods, avoid alcohol, bright lights and glare, excessive emotion, and
stress as these may precipitate attacks
Encourage patient to focus on validity, natural history, and pathology of the condition
Patient education
Recurrence of the headaches is possible; patients should contact their physician and
start treatment if this happens
Resources
Summary of evidence
Evidence
Oxygen:
In an RCT crossover study to assess the superiority of high-flow oxygen for the
treatment of cluster headache to placebo, 109 adult subjects treated four bouts
of cluster headache with inhaled high-flow oxygen or placebo, alternately. The
treatment regimen with oxygen included inhaled oxygen at 100%, 12 L/min,
which was delivered by face mask for 15 minutes at the start of an attack of
cluster headache, or high-flow air placebo, which was delivered alternately for
four bouts of headache. The aims of this study included rendering the study
subjects pain free, rendering them pain free at 30 minutes, pain reduction up to
30 minutes, decreased use of rescue therapy, and reduction of functional
disability. Only 57 subjects with episodic cluster headache and 19 subjects with
chronic cluster headache were available for the data analysis. Assessment of the
data demonstrated that the difference for the primary end point between
oxygen therapy (78%) and inhalation of air (20%) was statistically significant.
The treatment was not associated with any significant adverse events. [2] Level of
evidence: 1
Triptans:
A systematic review of six trials with a total of 999 study subjects determined
the efficacy and tolerability of a single dose of triptan for the treatment of acute
attacks of cluster headache. In total, 231 patients were treated with zolmitriptan
5 mg, 223 patients with zolmitriptan 10 mg, 131 patients with sumatriptan 6 mg,
88 patients with sumatriptan 12 mg, and 326 patients were on placebo.
Zolmitriptan was given orally or intranasally, and sumatriptan was
administered either subcutaneously or intranasally. In general, the triptans
used in these trials demonstrated superiority over placebo for headache relief
and pain-free responses, with an NNT of 2.4 for 15-minute pain relief with
subcutaneous sumatriptan 6 mg (75% with sumatriptan and 32% with placebo),
and an NNT of 2.8 for 30-minute pain relief with intranasal zolmitriptan 10 mg
(62% with zolmitriptan and 26% with placebo). Smaller numbers of patients
who were treated with triptans required rescue therapy compared to the
placebo group; however, adverse events were more frequent in the treatment
group. The authors concluded that both zolmitriptan and sumatriptan were
effective in the treatment of acute bouts of cluster headache, were more
convenient than oxygen treatment, and demonstrated better safety and
tolerability profiles than ergotamine. Administration of the medication via non-
oral routes was associated with faster therapeutic response and relief. [6] Level of
evidence: 1
Prednisone:
In a study of 19 patients with cluster headaches whose pain was not mitigated
by standard treatment, a double-blind control study with single crossover
showed sustained improvement on oral prednisone compared with placebo in
17 cases. [7] Level of evidence: 3
Dihydroergotamine:
Lidocaine:
Verapamil:
A small RCT compared the efficacy of verapamil versus placebo in the
prophylaxis of episodic cluster headache. There was a significant reduction in
the frequency of attacks and in the consumption of abortive agents in the
verapamil-treated group, suggesting that verapamil is effective in episodic
cluster headache prophylaxis. [10] Level of evidence: 2
Lithium:
Civamide:
References
References
Evidence references
1. Fogan L. Treatment of cluster headache. A double-blind comparison of oxygen v
air inhalation. Arch Neurol. 1985;42:362-3
View In Article (refInSitucid_04531)
2. Cohen AS, Burns B, Goadsby PJ. High-flow oxygen for treatment of cluster
headache: a randomized trial. JAMA. 2009;302:2451-7
View In Article (refInSitu53551) | CrossRef (http://dx.doi.org/10.1001%2Fjama.2009.1855)
5. van Vliet JA, Bahra A, Martin V, et al. Intranasal sumatriptan in cluster headache:
randomized placebo-controlled double-blind study. Neurology. 2003;60:630-3
View In Article (refInSitucid_04538)
6. Law S, Derry S, Moore RA. Triptans for acute cluster headache. Cochrane Database
Syst Rev. 2010:CD008042
View In Article (refInSitu53553) | CrossRef (http://dx.doi.org/10.1002%2F14651858.CD008042.pub2)
7. Jammes JL. The treatment of cluster headaches with prednisone. Dis Nerv Syst.
1975;36:375-6
View In Article (refInSitucid_04532)
9. Costa A, Pucci E, Antonaci F, et al. The effect of intranasal cocaine and lidocaine
on nitroglycerin-induced attacks in cluster headache. Cephalalgia. 2000;20:85-91
View In Article (refInSitucid_04530) | CrossRef (http://dx.doi.org/10.1046%2Fj.1468-
2982.2000.00026.x)
11. Bussone G, Leone M, Peccarisi C, et al. Double blind comparison of lithium and
verapamil in cluster headache prophylaxis. Headache. 1990;30:411-7
View In Article (refInSitucid_04529) | CrossRef (http://dx.doi.org/10.1111%2Fj.1526-
4610.1990.hed3007411.x)
12. Saper JR, Klapper J, Mathew NT, Rapoport A, Phillips SB, Bernstein JE. Intranasal
civamide for the treatment of episodic cluster headaches. Arch Neurol. 2002;59:990-
4
View In Article (refInSitu53554)
Guidelines
The American Academy of Neurology (http://www.aan.com/)has produced the following:
Francis GJ, Becker WJ, Pringsheim TM. Acute and preventive pharmacologic treatment of
cluster headache (http://www.neurology.org/content/75/5/463.full.pdf). Neurology.
2010;75:463-73 (registration required)
The National Clinical Guideline Centre (http://www.ncgc.ac.uk/), UK, has produced the following:
Edlow JA, Panagos PD, Godwin SA, Thomas TL, Decker WW. Clinical policy: critical
issues in the evaluation and management of adult patients presenting to the emergency
department with acute headache (http://www.annemergmed.com/article/S0196-
0644%2808%2901463-7/fulltext). Ann Emerg Med. 2008;52:407-36
May A, Leone M, Afra J, et al, and the EFNS Task Force. EFNS guidelines on the
treatment of cluster headache and other trigeminal-autonomic cephalalgias
(http://onlinelibrary.wiley.com/doi/10.1111/j.1468-1331.2006.01566.x/full). Eur J Neurol.
2006;13:1066-77 (registration required)
Further reading
Walker RA, Wadman MC. Headache in the elderly. Clin Geriatr Med.
2007;23:291-305
Lipton RB, Bigal ME, Steiner TJ, Silberstein SD, Olesen J. Classification of primary
headaches. Neurology. 2004;63:427-35
Weintraub JR. Cluster headaches and sleep disorders. Curr Pain Headache Rep.
2003;7:150-6
Cohen AS, Burns B, Goadsby PJ. High-flow oxygen for treatment of cluster
headache: a randomized trial. JAMA. 2009;302:2451-7
Brittain JS, Green AL, Jenkinson N, et al. Local field potentials reveal a
distinctive neural signature of cluster headache in the hypothalamus.
Cephalalgia. 2009;29:1165-73
Codes
ICD-9 code
339.00 Cluster headache syndrome, unspecified
ICD-10 code
G44.00 Cluster headache syndrome, unspecified
FAQ
What are the headaches classified under trigeminal autonomic cephalgias?
Cluster headache, paroxysmal hemicrania, short-lasting unilateral neuralgiform
headache attacks with conjunctival injection and tearing (SUNCT), and hemicrania
continua. These headaches are primary headache syndromes, which are
recognized by the presence of headache along with autonomic features
What is the relationship between the cluster headache and the patient's stage
of sleep? Cluster headaches possess a preference for the first REM sleep phase;
therefore, the patient wakes up with a severe headache within 60 to 90 minutes of
falling asleep
What are the common triggers associated with cluster headache? Chronic
tobacco use, obstructive sleep apnea, and alcohol overuse
Current contributors
Alireza Minagar, MD, FAAN, FANA, Professor, Department of Neurology, Louisiana State
University Health Sciences Center, Shreveport, Louisiana